| Patents for A61P 37 - Drugs for immunological or allergic disorders (117,141) |
|---|
| 09/19/2007 | CN101039691A Compositions and methods for treating neurological disorders |
| 09/19/2007 | CN101037651A Lucidum mushroom health wine and production method thereof |
| 09/19/2007 | CN101037481A Loose knot total polysaccharide and preparation method and usage thereof |
| 09/19/2007 | CN101037473A R. grahami rnmunoregulating polypeptide, gene and variant and its application in medicine production |
| 09/19/2007 | CN101037438A Compositions useful as inhibitors of GSK-3 |
| 09/19/2007 | CN101036786A Immunomodulation agent with adjuvant having function for treating atherosclerosis |
| 09/19/2007 | CN101036744A A medicine composition, the preparing method and the function |
| 09/19/2007 | CN101036723A Effective Chinese traditional medicine having a function of invigorating kidney and strengthening resistance and solidifying health |
| 09/19/2007 | CN101036698A Mulberry leaf extract and its preparing process and application |
| 09/19/2007 | CN101036691A Health-caring product for improving bone density and immunity |
| 09/19/2007 | CN101036675A Method for extracting flavonoids from the waxberry core |
| 09/19/2007 | CN101036674A Injection including polysaccharides from ginkgo biloba |
| 09/19/2007 | CN101036664A Application of Di-wu extractive monocase in the preparation of material of Chinese traditional medicine |
| 09/19/2007 | CN101036649A Function of ascomycin used as the immunosuppressor |
| 09/19/2007 | CN101036644A Pharmaceutical composition containing arctigenin and preparation method |
| 09/19/2007 | CN101036643A Pharmaceutical composition containing arctigenin and preparation method |
| 09/19/2007 | CN100338086C Immunostimulatory nucleic acid molecules |
| 09/19/2007 | CN100338085C Sialic carbohydrates |
| 09/19/2007 | CN100338084C Synthetic method for pentose antigen for inhibiting heterogenic organ transplant immune rejection reaction |
| 09/19/2007 | CN100338062C Azaindoles as inhibitors of c-Jun N-terminal kinases |
| 09/19/2007 | CN100338061C Alkyne-aryl phosphodiesterase-4 inhibitors |
| 09/19/2007 | CN100338044C HIV protease inhibitors, compositions containing the same, their pharmaceutical uses and materials for their synthesis |
| 09/19/2007 | CN100338042C Triazole derivatives as cyclooxygenase (COX) inhibitors |
| 09/19/2007 | CN100337684C Thymic pentapeptide aqua prepn and its prepn process and application |
| 09/19/2007 | CN100337676C Erythromelalgia treating medicine |
| 09/19/2007 | CN100337643C Effervescent tablets contg. Astragalus root and fructus ligustric lucidi for strengthening the body resistance, and its prepn. art |
| 09/19/2007 | CN100337640C Application of germanium enriched golden needle fungus in preparation of medicine for treating lupus erythematosus |
| 09/18/2007 | USRE39847 Method of treating a systemic disease |
| 09/18/2007 | US7271192 Nitrogen oxide synthase inhibitors; synthesis |
| 09/18/2007 | US7271181 Inhibitors of p38 |
| 09/18/2007 | US7271179 Inhibitors of JAK protein kinase |
| 09/18/2007 | US7271177 Solubility, dissolution rate and bioavailability; X-ray diffraction peak pattern comprising broad halo at 2 theta of about 17 degrees |
| 09/18/2007 | US7271171 Adenosine A3 receptor modulators |
| 09/18/2007 | US7271156 Immunostimulatory nucleic acids |
| 09/18/2007 | US7271144 Therapeutic fibrin-derived peptides and uses thereof |
| 09/18/2007 | US7270839 Process of obtaining thylakoids from photosynthetic organisms; plant fractions obtained from the process; pure thylakoids; and methods of use of thylakoids as ROS scavengers, photo-protectors, biosensors, biofilters and bioreactors |
| 09/18/2007 | US7270827 For prophylaxis and therapy of microbial infection and eliciting a protective immune response |
| 09/18/2007 | CA2329077C Pyrazolopyrimidinone cgmp pde5 inhibitors for the treatment of sexual dysfunction |
| 09/18/2007 | CA2319609C Oral liquid formulations of benzoxazinones hiv reverse transcriptase inhibitors |
| 09/18/2007 | CA2270952C New use for 1,3-propanediol derivatives |
| 09/18/2007 | CA2263362C Bi-aromatic compounds and pharmaceutical and cosmetic compositions containing same |
| 09/18/2007 | CA2259621C Isocoumarin derivatives and their use in medicines |
| 09/18/2007 | CA2221991C Di- and trivalent small molecule selectin inhibitors |
| 09/18/2007 | CA2185541C Cytotoxic t-cell epitopes |
| 09/18/2007 | CA2181568C Use of interleukin-12 to prevent graft versus host disease |
| 09/18/2007 | CA2124605C Prevention and improvement of medical symptoms caused by leucotriene b4 |
| 09/13/2007 | WO2007103348A2 Process for preparing water-soluble polyethylene glycol conjugates of macrolide immunosuppressants |
| 09/13/2007 | WO2007102769A2 Piperidine derivatives, their process for preparation, their use as therapeutic agents and pharmaceutical compositions containing them |
| 09/13/2007 | WO2007102768A1 Piperidine derivatives, their process for preparation, their use as therapeutic agents and pharmaceutical compositions containing them . |
| 09/13/2007 | WO2007102767A1 Piperidine derivatives, their process for preparation, their use as therapeutic agents and pharmaceutical compositions containing them |
| 09/13/2007 | WO2007102326A1 Strong immune induction by using combination of adenovirus type-5/type-35 vector and vaccinia virus mva vector |
| 09/13/2007 | WO2007102011A1 The use of beta-aminoalcohols for the treatment of inflammatory disorders and pain |
| 09/13/2007 | WO2007102008A1 The use of beta-aminoalcohols in the treatment of inflammatory disorders and pain |
| 09/13/2007 | WO2007101850A1 Use of adenine-derived compounds for the treatment of lupus |
| 09/13/2007 | WO2007101365A1 New flavane compound and its uses |
| 09/13/2007 | WO2007082808A3 Thiazoles as 11 beta-hsd1 inhibitors |
| 09/13/2007 | WO2007047468A3 Immunomodulation using placental stem cells |
| 09/13/2007 | WO2007033230A3 Anti-cd3 antibody formulations |
| 09/13/2007 | WO2007022511A3 Listeria-induced immunorecruitment and activation, and methods of use thereof |
| 09/13/2007 | WO2006096487A3 Methods and compositions for modulating tweak and fn14 activity |
| 09/13/2007 | WO2003072719A3 Metapneumovirus strains and their use in vaccine formulations and as vector for expression of antigenic sequences |
| 09/13/2007 | US20070213546 (20R)-1 alpha ,25-dihydroxy-2-[3'-hydroxypropylidene]-19-norvitamin D3; high intestinal calcium transport activity; ability to mobilize calcium from bone; bone replacement surgeries, autoimmune diseases, multiple sclerosis, diabetes mellitus,lupus, antiproliferative agents |
| 09/13/2007 | US20070213401 Pharmaceutical uses for alpha2delta ligands |
| 09/13/2007 | US20070213387 Such as 3-[2-[3-(dimethylamino)-2-hydroxypropoxy]phenyl]-4-(1-ethenyl-1H-indol-3-yl)-1H-pyrrole-2,5-dione; protein kinase C inhibitors; for treatment of diabetes |
| 09/13/2007 | US20070213386 protein kinase C or glycogen synthase kinase-3-beta inhibitors such as 3-[2-[3-(dimethylamino)-2-hydroxypropoxy]phenyl]-4-(1-ethenyl-1H-indol-3-yl)-1H-pyrrole-2,5-dione, used for treating diabetes, dementias such as Alzheimer's disease and bipolar disorders |
| 09/13/2007 | US20070213291 Therapeutically useful synthetic oligonucleotides |
| 09/13/2007 | US20070212758 Methods for the production of 3-o-deactivated-4'-monophosphoryl lipid a (3d-mla) |
| 09/13/2007 | US20070212753 Altered antibodies and their preparation |
| 09/13/2007 | US20070212714 Novel genes TZap7/A, TZap7/B and TZap7 involved in T cell activation and uses thereof |
| 09/13/2007 | US20070212302 Preparation and Use of a Stable Formulation of Allosteric Effector Compounds |
| 09/13/2007 | US20070212297 Amino methyl imidazoles and related compounds as C5a receptor modulators |
| 09/13/2007 | CA2646883A1 The use of beta-aminoalcohols for the treatment of inflammatory disorders and pain |
| 09/13/2007 | CA2646882A1 The use of beta-aminoalcohols in the treatment of inflammatory disorders and pain |
| 09/13/2007 | CA2645093A1 Use of adenine-derived compounds for the treatment of lupus |
| 09/13/2007 | CA2645053A1 Immunomodulatory compounds and treatment of diseases related to an overproduction of inflammatory cytokines |
| 09/13/2007 | CA2644156A1 Process for preparing water-soluble polyethylene glycol conjugates of macrolide immunosuppressants |
| 09/13/2007 | CA2644020A1 Prolongation of survival of an allograft by inhibiting complement activity |
| 09/12/2007 | EP1832657A1 Methylation of plasmid vectors |
| 09/12/2007 | EP1832605A1 Neural cell adhesion molecule (NCAM) binding antibodies |
| 09/12/2007 | EP1832599A2 Albumin fusion proteins |
| 09/12/2007 | EP1832592A2 15-C Isomers of rapamycin and of 42-EPI rapamycin, preparation and use thereof |
| 09/12/2007 | EP1832590A2 Tri- heterocyclic compounds and a pharmaceutical comprising them as an active ingredient |
| 09/12/2007 | EP1832588A1 Condensed imidazole compound and use thereof |
| 09/12/2007 | EP1832580A1 Crystal and salt of 1-cyclopropylmethyl-4-ý2-(3,3,5,5)-tetramethylcyclohexyl)phenyl¨piperazine |
| 09/12/2007 | EP1832287A2 The use of anti-histaminics for acute reduction of elevated intracranial pressure |
| 09/12/2007 | EP1832279A2 A process for the preparation of suspensions of drug particles for inhalation delivery |
| 09/12/2007 | EP1831209A2 Cdc25 phosphatase inhibitors |
| 09/12/2007 | EP1831168A1 Pyrid-2-ones useful as inhibitors of tec family protein kinases for the treatment of inflammatory, proliferative and immunologically-mediated diseases. |
| 09/12/2007 | EP1830881A2 Combining therapies targeting multiple toll-like receptors and use thereof |
| 09/12/2007 | EP1830880A2 Multi-route administration of immune response modifier compounds |
| 09/12/2007 | EP1830868A1 Dap-10 and uses thereof |
| 09/12/2007 | EP1830861A2 Antiviral and immunostimulating marine fish oil composition |
| 09/12/2007 | EP1830857A2 Treatment of graft-versus-host disease and leukemia with beclomethasone dipropionate and prednisone |
| 09/12/2007 | EP1830801A2 Drop preparations comprising dimetindene |
| 09/12/2007 | EP1526860B1 Bioavailability/bioefficacy enhancing activity of cuminum cyminum and extracts and fractions thereof |
| 09/12/2007 | EP1395566B1 Tricyclic compounds useful as angiotensin ii agonists |
| 09/12/2007 | EP1307564B1 Compounds and methods for treatment and diagnosis of chlamydial infection |
| 09/12/2007 | EP1303496B1 Pyrimidine derivatives |
| 09/12/2007 | EP1268305B1 Infusion packet with useful and decorative elements, support member, delivery system and method |
| 09/12/2007 | EP1212366B1 Therapeutic compounds comprised of anti-fc receptor binding agents |